Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRR1 | P24046 | 5/20 | 0.50 |
| ▸ | POLB | P06746 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | GABRR2 | P28476 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 5/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 3/20 | 0.39 |
| ▸ | APEX1 | P27695 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | GMNN | O75496 | 1/20 | 0.39 |
| ▸ | TFPI2 | P48307 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | THPO | P40225 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | GRM8 | O00222 | 1/20 | 0.39 |
| ▸ | GRM6 | O15303 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2885177 | 0.97 | GABRR1 (0.48) | GABRR1POLBTDP1GABRR2LMNA | |
| Hydrochloric Acid SCHEMBL2384923 | 0.97 | GABRR1 (0.48) | GABRR1POLBTDP1GABRR2LMNA | |
| SCHEMBL2697233 | 0.93 | GABRR1 (0.50) | GABRR1POLBTDP1GABRR2LMNA | |
| SCHEMBL770971 | 0.93 | GABRR1 (0.50) | GABRR1POLBTDP1GABRR2LMNA | |
| SCHEMBL2696513 | 0.93 | GABRR1 (0.50) | GABRR1POLBTDP1GABRR2LMNA | |
| SCHEMBL9782991 | 0.93 | GABRR1 (0.50) | GABRR1POLBTDP1GABRR2LMNA | |
| SCHEMBL22039 | 0.93 | GABRR1 (0.50) | GABRR1POLBTDP1GABRR2LMNA | |
| SCHEMBL8628131 | 0.93 | GABRR1 (0.50) | GABRR1POLBTDP1GABRR2LMNA | |
| SCHEMBL13084744 | 0.93 | GABRR1 (0.50) | GABRR1POLBTDP1GABRR2LMNA | |
| SCHEMBL503468 | 0.93 | GABRR1 (0.50) | GABRR1POLBTDP1GABRR2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114790270-A | Moisture-curable polyurethane hot-melt resin composition, cured product, and laminate | DIC株式会社 | 2022-07-26 | — | — | CN | disclosed |
| CN-101821089-B | Polymeric membranes incorporating nanotubes | UNIV SINGAPORE | 2014-12-10 | — | — | CN | disclosed |
| US-7872148-B2 | Cage-shaped cyclobutanoic dianhydrides and process for production thereof | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2011-01-18 | — | — | US | disclosed |
| CN-101821089-A | Polymeric membranes incorporating nanotubes | UNIV SINGAPORE | 2010-09-01 | — | — | CN | disclosed |
| US-20090012318-A1 | Cage-shaped cyclobutanoic dianhydrides and process for production thereof | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2009-01-08 | — | — | US | disclosed |
| US-6808766-B1 | ALIGNMENT AGENT COMPRISING POLYURETHANE OR POLYUREA, USED IN ALIGNMENT OF LIQUID CRYSTAL MOLECULES THAT FORM LIQUID CRYSTAL ALIGNMENT FILM BY IRRADIATING THIN ALIGNMENT FILM FORMED ON SUBSTRATE WITH POLARIZED LIGHT OR ELECTRON RAYS | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2004-10-26 | — | — | US | disclosed |
| EP-0821665-B1 | CYCLOBUTANE DERIVATIVES AS INHIBITORS OF SQUALENE SYNTHASE AND PROTEIN FARNESYLTRANSFERASE | ABBOTT LAB (US) | 2001-10-04 | — | — | EP | disclosed |
| EP-1111442-A1 | TREATING AGENT FOR LIQUID CRYSTAL ALIGNMENT LAYER AND LIQUID CRYSTAL DEVICE USING THE SAME, AND METHOD FOR ALIGNMENT OF LIQUID CRYSTAL | Nissan Chemical Industries, Ltd. (JP) | 2001-06-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090012318-A1 | Cage-shaped cyclobutanoic dianhydrides and process for production thereof | ADH1C, ADH1A, ADH5 | GABRR1 292/4885POLB 249/4885TDP1 2154/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.